Figure 2. Morbidity in 816 MTF Transgender Women Treated with Cross-Gender Hormones

This table shows the observed morbidity for a subset of disorders in 816 Dutch male-to-female transsexuals treated with cross-gender hormones compared with morbidity observed in the general male population. The standardized incidence ratio (SIR) with 95% confidence intervals are shown. Data from: van Kesteren P, Asscheman H, Megens JA, Gooren LJ. Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf). 1997;47:337-42.

[Close Window]